Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15Carcinoma, Hepatocellular 8Neoplasm Metastasis 3Rectal Neoplasms 2Melanoma 2Cholangiocarcinoma 2Advanced Colorectal Cancer 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Tertiary Lymphoid Structures 1TAS 102 1Stomach Neoplasms 1Sarcoma 1Mesothelioma, Malignant 1Liver Neoplasms 1Gastrointestinal Stromal Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Fatigue 1Colorectal Cancer Metastatic 1Colorectal Cancer Liver Metastases 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Biliary Tract Neoplasms 1Asian Colorectal Cancer Patients 1Advanced Colorectal Carcinoma 1Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy 1

Interventions

regorafenib 1Radiofrequency Ablation 1Nivolumab 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Cancer Liver Metastases × regorafenib × Clear all
NCT05485909 2022-08-03

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Sun Yat-sen University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡